- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC in the Press, August 26, 2016
A review of our peer-reviewed research, in the healthcare and mainstream press.
Studies from the current issue of The American Journal of Managed Care have been cited frequently this week.
New research from the CVS Health Research Institute was one of the most-cited articles this week. The study found that interventions to keep patients with common chronic conditions on their medication are very cost effective, especially if those interventions target patients who take 3 or more medications. Payers can save between $38 million and $63 million per 100,000 members by focusing on these patient populations. Multiple outlets cited the study, including The Pharmacist, the official publication of the American Pharmacist Association.
In addition, the Center for Infectious Disease Research and Policy at the University of Minnesota discussed an article by CDC authors, who found that more than three-fourths of adults diagnosed as having bronchitis receive an antibiotic, even though antibiotics are not indicated for this condition.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
ERISA Industry Committee Sues Minnesota Over PBM Law
January 3rd 2025The Employee Retirement Income Security Act (ERISA) Industry Committee filed a legal challenge against the Minnesota Department of Commerce, arguing that Minnesota’s Pharmacy Benefit Manager (PBM) Licensure and Regulation Act illegally interfered with employer-sponsored health plans by restricting plan design options and increasing costs.
Read More
